The cost of medication treatment for multiple sclerosis in Spain typically ranges from $3,000 to $6,000. Pricing varies depending on the specific drug (injectable, oral, or infusion therapies), the clinic or hospital, and whether additional services like neurologist consultations or MRI monitoring are included. In the United States, the average cost is $18,500 (per National MS Society). This means MS medication treatments in Spain are about 76% less than in the U.S.
Spanish clinics usually include the neurologist’s evaluation, prescription, drug administration (if infusion), and routine follow-up visits in the price. In the U.S., medication costs often cover only the drug, with separate bills for doctor consultations, MRI scans, and lab work. Always confirm which services and medications are included with your chosen clinic.
Why do patients choose Spain for medication treatment for multiple sclerosis?
Access advanced Medication treatment for multiple sclerosis solutions in trusted clinics .
| Turkey | Austria | Spain | |
| Medication treatment for multiple sclerosis | from $2,500 | from $2,000 | from $3,000 |
| Ocrevus (ocrelizumab) | from $10,000 | from $35,000 | from $25,000 |
Medically reviewed by
Fahad MawloodNo hidden fees – just official clinic prices. Pay at the clinic for Medication treatment for multiple sclerosis upon arrival and use a flexible installment plan if needed.
Bookimed is committed to your safety. We only work with medical institutions that maintain high international standards in Medication treatment for multiple sclerosis and have the necessary licenses to serve international patients worldwide.
Bookimed offers free expert assistance. A personal medical coordinator supports you before, during, and after your treatment, solving any issues. You're never alone on your Medication treatment for multiple sclerosis journey.
Day 1
Day 2
Day 3
Day 4 to Day 14
Week 3
Week 4
Week 5
Note: Each patient"s journey with multiple sclerosis differs. This plan is a general guideline and may be adjusted based on individual needs.
Principal investigator in 100+ clinical trials for multiple sclerosis – Dr. Arroyo leads groundbreaking research at Quironsalud Madrid.
Dr Romero Imbroda is a Fellow of the European Board of Neurology and President of the Andalusian Society of Neurology, specializing in multiple sclerosis treatment.
Dr. Rodrigo Rocamora Zuniga is a neurologist who specializes in epilepsy. He leads the epilepsy department at HM Delfos Hospital in Spain. He is also a professor at UPF University. Dr. Rocamora earned his PhD from Bonn University in 2001. He completed his neurology training at Pontificia Universidad Católica de Chile and received his medical degree in Mendoza, Argentina.
Dr. Rocamora is accredited by the European Reference Network. He is an active member of SEN, CSUR, and EPI-Care. He has published over 100 scientific articles on drug-resistant epilepsy, epilepsy surgery, and cognitive impairment. His work has helped develop new protocols that have improved care for epilepsy patients.